Article Information
History
- December 23, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Susanne Rauch#,1,*,
- Karen Gooch#,2,
- Yper Hall2,
- Francisco J. Salguero2,
- Mike J. Dennis2,
- Fergus V. Gleeson3,
- Debbie Harris2,
- Catherine Ho2,
- Holly E. Humphries2,
- Stephanie Longet2,
- Didier Ngabo2,
- Jemma Paterson2,
- Emma L. Rayner2,
- Kathryn A. Ryan,
- Sally Sharpe2,
- Robert J. Watson2,
- Stefan O. Mueller1,
- Benjamin Petsch+,1 and
- Miles W. Carroll#,2
- 1CureVac AG Tuebingen, Germany
- 2Public Health England, Porton Down, Salisbury, Wiltshire, SP4 0JG, United Kingdom
- 3Department of Oncology, University of Oxford, United Kingdom
- ↵*Corresponding authors
: susanne.rauch{at}curevac.com
Posted December 23, 2020.
mRNA vaccine CVnCoV protects non-human primates from SARS-CoV-2 challenge infection
